Cellares
Cellares is a biotechnology and cell therapy company founded in 2019 by Fabian Gerlinghaus, Alex Pesch, and Omar Kurdi.
1
Funding Rounds
$82.0m
Money raised
Overview
Cellares is a biotechnology and cell therapy company founded in 2019 by Fabian Gerlinghaus, Alex Pesch, and Omar Kurdi.
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Al** Pe*** | - | - | |
| Fa**** Ge********* | - | - | linkedin twitter facebook |
| Om** Ku*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Vi**** To** | - | - | linkedin twitter instagram |
| Name | Phone | Social networks | |
|---|---|---|---|
| Fa**** Ge********* | - | - | linkedin twitter facebook |
| Om** Ku*** | - | - |
Funding series
Funding Series Analysis
The company Cellares has raised a total of $82m in funding over 1 rounds.
Key Insights:
- Cellares Series B round, May 2021: $82m
Cellares Series B round, May 2021
$82m
Industries
Cellares is active in the following industries:
- Immunotherapy
- Cell therapy
- Biomedical engineering
- Biopharmaceutical
- Technology
- Biotechnology
- Regenerative medicine
- Tissue engineering
- Biology
- Healthcare
- B2B
- Engineering